Missouri-based Sparo Labs has received FDA "over-the-counter" approval for its app-connected spirometer, Wing. The device plugs into a smartphone and, via an app, allows people with respiratory conditions such as asthma to track their lung function. The results are then given using a traffic-light system. In the study, researchers found that users of the app were able to improve their performance by up to 20 percent compared to those who used traditional methods.
Missouri-based Sparo Labs has received FDA "over-the-counter" approval for its app-connected spirometer, Wing. The device plugs into a smartphone and, via an app, allows people with respiratory conditions such as asthma to track their lung function. The results are then given using a traffic-light system. Sparo currently has no agreements with healthcare providers or pharmaceutical companies and is targeting patients as its primary audience in the short term.